Low Dose Methotrexate

DRUG3 trials

Sponsors

University of Michigan Rogel Cancer Center, Massachusetts General Hospital, Icahn School of Medicine at Mount Sinai

Conditions

AtherosclerosisAtherosclerotic Cardiovascular DiseaseFollicular LymphomaHIVInflammationVascular Inflammation

Phase 2

Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma

TerminatedNCT01389076

University of Michigan Rogel Cancer CenterFollicular Lymphoma

Start: 2011-07-31End: 2016-06-30Updated: 2017-01-30

Phase 3

Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study

CompletedNCT02576067

Icahn School of Medicine at Mount SinaiAtherosclerotic Cardiovascular Disease, Vascular Inflammation

Start: 2015-12-18End: 2019-03-29Updated: 2020-04-20

Unknown Phase

PET/CT Imaging Companion Study To ACTG A5314

CompletedNCT02312219

Massachusetts General HospitalAtherosclerosis, HIV, Inflammation

Start: 2014-11-30End: 2016-12-08Updated: 2019-02-06